{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T02:35:11.550799",
  "document": "Mal-de-Debarquement.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/test/Mal-de-Debarquement.pdf",
  "pipeline_version": "0.8",
  "total_candidates": 2,
  "total_validated": 2,
  "total_rejected": 0,
  "total_investigational": 0,
  "drugs": [
    {
      "matched_text": "adapt",
      "preferred_name": "ADAPT",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "D017438",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "614919",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "D017438",
          "display": "Bisphenol A-Glycidyl Methacrylate"
        }
      ],
      "context": "nt once the stimulus (trigger) has ended. It is as yet undetermined as to the cause of the balance system’s inability to appropriately compensate and adapt. How or why this happens remains a mystery. The majority of people affected are adult females, although there have been reports of males having the d",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "adaptaquin"
      ],
      "pubtator_normalized_name": "Bisphenol A-Glycidyl Methacrylate",
      "enrichment_source": "pubtator3"
    },
    {
      "matched_text": "ocean",
      "preferred_name": "Ocean",
      "brand_name": null,
      "compound_id": null,
      "confidence": 0.7,
      "is_investigational": false,
      "drug_class": null,
      "mechanism": null,
      "development_phase": null,
      "sponsor": null,
      "conditions": [],
      "nct_id": null,
      "dosage_form": null,
      "route": null,
      "marketing_status": null,
      "codes": {
        "rxcui": null,
        "mesh": "C404387",
        "ndc": null,
        "drugbank": null,
        "unii": null
      },
      "all_identifiers": [
        {
          "system": "RxCUI",
          "code": "218843",
          "display": null
        },
        {
          "system": "MeSH",
          "code": "C404387",
          "display": "oceanapiside"
        }
      ],
      "context": "rough unknown mechanisms. The diagnosis of MDD still remains mostly clinical. As such, the history is very important. Persistent “dizziness” after an ocean cruise, a sailing trip, a prolonged airplane flight or a cross-country road trip is highly suggestive of MDD. Vestibular function tests in patients w",
      "page": 1,
      "mention_count": 1,
      "pages_mentioned": [
        1
      ],
      "lexicon_source": "2025_08_lexicon_drug.json",
      "validation_flags": [
        "lexicon_match",
        "pubtator_enriched",
        "deduplicated"
      ],
      "mesh_aliases": [
        "oceanalin A",
        "oceanapamine"
      ],
      "pubtator_normalized_name": "oceanapiside",
      "enrichment_source": "pubtator3"
    }
  ]
}